GILEAD SCIENCES, INC.

(GILD)
  Report
Delayed Nasdaq  -  05/17 04:00:00 pm EDT
63.18 USD   +1.51%
04:31pGilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting
BU
11:01aGilead Sciences, Inc. - FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV
AQ
10:29aWALL STREET STOCK EXCHANGE : Finding the tipping point
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on GILEAD SCIENCES, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) GILEAD SCIENCES, INC.
Analyst Recommendations on GILEAD SCIENCES, INC.
06:08aANALYST RECOMMENDATIONS : AMD, CarMax, Gilead, J.B. Hunt, Vodafone...
05:09aPiper Sandler Adjusts Gilead Sciences' Price Target to $69 From $73, Maintains Neutral Rat..
MT
05/13UBS Adjusts Gilead Sciences Price Target to $64 From $65, Maintains Neutral Rating
MT
04/29BMO Capital Adjusts Gilead Sciences Price Target to $63 From $65, Maintains Market Perform..
MT
04/29Piper Sandler Adjusts Gilead Sciences' Price Target to $73 From $72, Maintains Neutral Rat..
MT
04/12Morgan Stanley Lowers Gilead Sciences Price Target to $63 From $69, Maintains Euqalweight ..
MT
04/12RBC Raises Price Target on Gilead Sciences to $77 From $76 as FDA Lifts Partial Clinical H..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 63,18 $
Average target price 70,07 $
Spread / Average Target 10,9%
High Price Target 90,00 $
Spread / Highest target 42,5%
Low Price Target 56,00 $
Spread / Lowest Target -11,4%
Consensus detail
Consensus revision (last 18 months)